Defence Therapeutics to Present at the Life Sciences Virtual Investor Forum December 11th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com MONTREAL, Dec. 11, 2025 (GLOBE NEWSWIRE) — Defence Therapeutics (OTCQB: DTCFF), based in adMare BioInnovations Technop
(Financial Post, 2025-12-11T13:37:23Z)